首页> 美国卫生研究院文献>Haematologica >Distinct frequencies and mutation spectrums of genetic thrombophilia in Korea in comparison with other Asian countries both in patients with thromboembolism and in the general population
【2h】

Distinct frequencies and mutation spectrums of genetic thrombophilia in Korea in comparison with other Asian countries both in patients with thromboembolism and in the general population

机译:与血栓栓塞患者和一般人群相比韩国与其他亚洲国家相比遗传血栓形成的不同频率和突变谱

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Hereditary natural anticoagulant deficiencies are the major cause of genetic thrombophilia in Asia. Given the growing acknowledgment of the risk of venous thromboembolism in Asian populations, we investigated the frequency and mutation spectrums of natural anticoagulant deficiency in Korea. The group of patients consisted of consecutive patients with venous thromboembolism screened for thrombophilia. Genetic tests were performed on suspicion of natural anticoagulant deficiency. For the population group, >3,000 individuals were screened from routine check-ups, and those with a low level (<1st percentile) of natural anticoagulant underwent genetic tests. Mutations were detected by direct sequencing of PROC, PROS1, and SERPINC1, followed by additional multiplex ligation-dependent probe amplification for PROS1 and SERPINC1 for dosage mutations. Among 500 patients screened, 127 were suspected of having a natural anticoagulant deficiency, and this was genetically confirmed in 71: protein C deficiency in 36 (50.7%), antithrombin deficiency in 21 (29.6%), and protein S deficiency in 14 (19.7%). Among 3,129 individuals from the population who were screened, the frequency of natural anticoagulant deficiency was ~1.0%: antithrombin deficiency 0.49%, protein C deficiency 0.35%, and protein S deficiency 0.16%. Two PROC mutations causing type I protein C deficiency were prevalent (Arg211Trp and Met406Ile in patients and Arg211Trp in the population). Two SERPINC1 mutations causing type II antithrombin deficiency, Arg79Cys and Ser158Pro, were prevalent in the population group. This is the first study on the genetic epidemiology of natural anticoagulant deficiencies in Korea. The results demonstrated that the frequencies and spectrum of mutations underlying genetic thrombophilia in Korea are different not only from those in Caucasians but also those in other Asian populations.
机译:遗传性天然抗凝剂缺乏症是亚洲遗传性血栓形成的主要原因。鉴于越来越多的亚洲人群意识到静脉血栓栓塞的风险,我们调查了韩国天然抗凝剂缺乏的频率和突变谱。该组患者由筛查了血栓形成倾向的静脉血栓栓塞的连续患者组成。对怀疑天然抗凝缺乏症进行了基因测试。对于该人群,从常规检查中筛选出超过3,000人,对天然抗凝剂水平较低( st 百分位数)的人进行了基因检测。通过对PROC,PROS1和SERPINC1进行直接测序检测突变,然后针对剂量突变对PROS1和SERPINC1进行额外的多重连接依赖探针扩增。在接受筛查的500名患者中,有127名被怀疑患有天然抗凝剂缺乏症,并且在71例中通过遗传学证实:蛋白C缺乏症为36(50.7%),抗凝血酶缺乏症为21(29.6%)和蛋白S缺乏症为14(19.7)。 %)。在接受筛查的人口中的3129名个体中,天然抗凝剂缺乏症的发生频率约为1.0%:抗凝血酶缺乏症0.49%,C蛋白缺乏症0.35%和S蛋白缺乏症0.16%。普遍存在两种引起I型蛋白C缺乏的PROC突变(患者中为Arg211Trp和Met406Ile,人群中为Arg211Trp)。人群中普遍存在两种导致II型抗凝血酶缺乏症的SERPINC1突变,即Arg79Cys和Ser158Pro。这是韩国对天然抗凝剂缺乏症的遗传流行病学的首次研究。结果表明,韩国遗传性血友病的突变频率和频谱不仅与白种人不同,而且与亚洲其他人群不同。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号